Similar to our metformin strategy above, we initially wanted to evaluate the mRNA expression levels of these target genes in the triceps of both symptomatic P7 severe Smn−/−;SMN2 and P19 milder Smn2B/− SMA mice alongside their respective healthy controls. This evidence concerns the gene SMN1 and proximal spinal muscular atrophy.